N@N

48.5% Of All NASDAQ Trading Yesterday Was Short Selling. DWCH, DXCM, BBX, WPRT, LIZ, KERX With Highest % Of Daily Trading Volu

^{Published on 2009-08-27 09:38:21, Last Modified on 2010-12-22 14:41:29 - WOPRAI}
 

August 27, 2009 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net, has reviewed the NASDAQ Daily Short Volume Report for Wednesday, August 26th, 2009 and come to the following statistical conclusions. There were 6,532 stocks with daily short volume reported and total NASDAQ trading volume of 1,554,786,334 shares. Total Daily Short Volume was 755,261,585 shares. 48.57% of all trading on the NASDAQ yesterday was short selling. The chart below highlights 6 stocks that had unusually high percentages of their total daily trading volume attributed to short sales. Datawatch (NASDAQ: DWCH), DexCom (NASDAQ: DXCM), BankAtlantic Bancorp (NYSE: BBX), Westport Innovations (NASDAQ: WPRT), Liz Claiborne (NYSE: LIZ) and Keryx Biopharmaceuticals (NASDAQ: KERX). To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.buyins.net.

DATE SYMBOL SHORT VOLUME TOTAL VOLUME MARKET PERCENT

20090826 DWCH 122,159 122,459 Q 99.76%

20090826 DXCM 146,261 166,535 Q 87.83%

20090826 BBX 113,806 144,006 Q 79.03%

20090826 WPRT 178,854 227,013 Q 78.79%

20090826 LIZ 421,821 552,021 Q 76.41%

20090826 KERX 165,707 219,360 Q 75.54%

In late October 2008 the SEC updated Regulation SHO requiring that all short sellers must locate, borrow and deliver any shares they have shorted, no exceptions, by T+3 settlement date. If not, a buy-in must be forced by the broker dealer that the short seller transacted through by the opening of the market on T+4. Since a company first appears on the naked short list when short sellers have been failing to deliver for 5 consecutive trading days, stocks should theoretically never be on the naked short list again. BUYINS.NET will monitor the exchangesa� naked short lists daily and issue an alert and notify the SEC and FINRA should short sellers fail to deliver on any short sales.

Reg SHO Rule 204 (i) requires brokers to deliver shares on long and short sales of publicly traded equity securities by settlement date, (ii) continues to require brokers to close-out fails to deliver by the beginning of trading on T+4 for short sales and T+6 for long sales, (iii) precludes clearing brokers and their introducing brokers from selling short a security, other than on a pre-borrowed basis, if a fail to deliver in that security is not timely closed out until the fail is closed out and that close-out transaction settles, (iv) allows clearing brokers to allocate fails to introducing brokers and (v) continues to permit brokers to rely upon pre-fail credit to satisfy Rule 204's close-out requirement to avoid the pre-borrow requirements when a fail at a clearing broker has not been closed out. However, the SEC liberalized certain of these provisions in several regards. For example, permanent Rule 204 now allows a broker to close-out a fail on a long sale by borrowing the security, whereas Rule 204T had only permitted closing out long fails by buying-in, which should alleviate some of the buy-in risk for investors that experience long fails. Similar relief was extended to close-outs for market maker fails, so that a fail from a bona fide market making transaction (including short and long fails) can now be closed out by the beginning of trading on T+6 by borrowing the security. Further, Rule 204 now permits a broker to borrow securities to obtain pre-fail credit for early close-outs, whereas temporary Rule 204T only permitted pre-fail credit to be obtained by purchases of securities.

The SEC refused requests to extend the close-out deadline for fails to deliver to the close of business on the close-out deadline, choosing instead to retain the requirement that all fails be closed out by the beginning of trading on the applicable close-out deadline. The Commission also rejected requests for a fail to deliver exception that would have provided an exception from the close-out requirements if a clearing broker's fail position was below a certain amount but said that it would continue to monitor whether a de minimis or odd lot exception could be warranted.

Datawatch Corporation (NASDAQ: DWCH) designs, develops, markets, and distributes business computer software products in the United States and internationally. Its products include Monarch that transforms structured text files into a live database that users can sort, filter, summarize, graph, and export to other applications; Monarch Data Pump that provides information delivery and data extract, transform, and load capabilities in one automated solution; Monarch BI Server, an out-of-the-box Web-based business intelligence solution for small to medium size businesses, and individual departments of large businesses; Monarch RMS, a Web-based report mining and analysis solution that integrates with enterprise record management, document, or content management archiving solutions; and Datawatch ES, an enterprise business intelligence system offering Web-enabled report management, mining, and distribution, as well as data analysis and MS Excel integration. The company also provides Datawatch BDS, a document archive system that stores text, as well as images, intelligent data streams, and unstructured content with file compression; Datawatch MailManager, an email management solution that provides lifecycle, compliance, and storage management for Microsoft Exchange environments; Visual Insight, a performance management solution that offers Web-based scorecarding, knowledge management, and key performance indicator reporting; Visual QSM, an Internet-enabled IT service management system; Visual Help Desk, an enterprise-wide support solution supporting an organizationa�s IT infrastructure; and VorteXML software that converts structured text output generated from various systems into valid XML for Web services using DTD or XDR schema without programming. Datawatch Corporation sells products through internal/external sales force, value-added partners, system integrators, distributors, and national resellers. The company was founded in 1985 and is headquartered in Chelmsford, Massachusetts.

DexCom, Inc. (NASDAQ: DXCM), a medical device company, engages in the design, development, and commercialization of continuous glucose monitoring systems for people with diabetes in the United States. The company offers FDA approved SEVEN, which includes a disposable sensor that can be inserted by a patient and used continuously for up to seven days; a transmitter; and a small handheld receiver. Its SEVEN system also received CE Mark approval for commercialization in the European Union and the countries in Asia and Latin America that recognize the CE Mark. DexCom has a collaboration agreement with Edwards Lifesciences LLC to develop products for continuously monitoring blood glucose levels in patients hospitalized for various conditions. The company was founded in 1999 and is headquartered in San Diego, California.

BankAtlantic Bancorp, Inc. (NYSE: BBX) operates as the bank holding company for BankAtlantic that provides retail and commercial banking products and services in Florida. It offers deposit products, including commercial demand deposit accounts, retail demand deposit accounts, savings accounts, money market accounts, certificates of deposit, various negotiable order of withdrawal accounts and individual retirement accounts, and Keogh retirement accounts. The companya�s lending portfolio comprises commercial real estate loans, commercial business loans, standby letters of credit and commitments, consumer loans, small business loans, and residential loans. As of December 31, 2008, it offered its services through approximately 100 branches in southeast and central Florida, and the Tampa Bay area, primarily in the Miami-Dade, Broward, Palm Beach, Hillsborough, and Pinellas counties. The company was founded in 1952 and is based in Ft. Lauderdale, Florida.

Westport Innovations Inc. (NASDAQ: WPRT) the research, development, and marketing of engines and fuel injection systems that use gaseous fuels, including natural gas, liquefied petroleum gas (LPG), hydrogen, and hydrogen-enriched compressed natural gas for the on-road commercial vehicle sector primarily in North America and Asia. The company offers engines utilizing gaseous fuels for transit and shuttle buses, conventional trucks and tractors, and refuse collection trucks, as well as specialty vehicles, such as short haul port drayage trucks, material handling trucks, street sweepers, and vehicles for selected industrial applications; direct injection LNG system for heavy-duty trucks; and engines fuelled with LPG primarily for the OEM forklift market. It also provides alternative fuel engines, and relevant parts and kits for use in automobiles, heavy duty trucks, power generation, and shipping applications; and cryogenic tanks for compressed natural gas or liquefied natural gas. The company was founded in 1995 and is headquartered in Vancouver, Canada.

Liz Claiborne Inc. (NYSE: LIZ), through its subsidiaries, engages in the design and marketing of a range of apparel and accessories worldwide. It offers womena�s, mena�s, and childrena�s contemporary apparel, denim and casual sportswear, intimate apparel, classic career and casual apparel for women, and activewear. The company also provides various accessories, including jewelry, handbags, and fragrances, as well as bath and body-care products. Liz Claiborne offers its products under the JUICY COUTURE, KATE SPADE, and LUCKY BRAND; and AXCESS, CLAIBORNE, CONCEPTS BY CLAIBORNE, KENSIE, LIZ & CO., LIZ CLAIBORNE, MAC & JAC, MARVELLA, MONET, TRIFARI, DKNY JEANS, DKNY ACTIVE, and DKNY MENS brand names, as well as under the MEXX brand. As of January 3, 2009, the company operated a total of 443 specialty retail stores, including 291 in the United States and 152 primarily in western Europe and Canada; and 365 outlet stores comprising 212 in the United States and 153 primarily in western Europe and Canada. It also engages in e-commerce and licensing operations relating to its various retail and wholesale brands. The company was founded in 1976 and is based in New York, New York.

Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of life-threatening diseases, including renal disease and cancer. Its products under development include Zerenex, an oral iron-based compound is in Phase II clinical development for the treatment of hyperphosphatemia in patients with end-stage renal disease in the United States and Japan; and KRX-0401, an oral anti-cancer agent in Phase II clinical development that modulates Akt, and various other key signal transduction pathways, including the JNK and MAPK pathways, which are pathways associated with programmed cell death, cell growth, cell differentiation, and cell survival. Keryx Biopharmaceuticals has strategic alliances with AEterna Zentaris Inc.; Panion & BF Biotech, Inc.; Japan Tobacco Inc.; and Torii Pharmaceutical Co., Ltd. for the manufacture and commercialization of its products. The company was formerly known as Lakaro Biopharmaceuticals, Inc. and changed its name to Keryx Biopharmaceuticals, Inc. in January 2000. Keryx Biopharmaceuticals, Inc. was founded in 1998 and is based in New York, New York.

About BUYINS.NET

WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.

BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2,650,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha�s short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. Occassionally companies or third parties pay $995 per month to purchase data for information provided in monthly reports. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

BUYINS.NET and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of BUYINS.NET, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor. By visiting BUYINS.NET or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. BUYINS.NET, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to BUYINS.NET and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State. Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. BUYINS.NET does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. BUYINS.NET places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.BUYINS.net +1-800-715-9999 Tom@buyins.net